- Home
- MAPS vs IBIO Comparison
MAPS vs IBIO Comparison
Compare MAPS & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MAPS | IBIO |
|---|---|---|
| Founded | 2008 | 2008 |
| Country | United States | United States |
| Employees | 449 | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 75.5M | 72.2M |
| IPO Year | N/A | 2009 |
Fundamental Metrics
Financial Performance| Metric | MAPS | IBIO |
|---|---|---|
| Price | $0.36 | $1.66 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | $2.61 | ★ $4.75 |
| AVG Volume (30 Days) | ★ 4.9M | 656.7K |
| Earning Date | 05-11-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 73.08 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $6.17 | N/A |
| P/E Ratio | $9.75 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.32 | $0.56 |
| 52 Week High | $1.36 | $3.82 |
Technical Indicators
Market Signals| Indicator | MAPS | IBIO |
|---|---|---|
| Relative Strength Index (RSI) | 33.93 | 30.68 |
| Support Level | $0.33 | $1.43 |
| Resistance Level | $0.75 | $1.81 |
| Average True Range (ATR) | 0.05 | 0.13 |
| MACD | -0.00 | -0.04 |
| Stochastic Oscillator | 12.23 | 0.00 |
Price Performance
Historical ComparisonAbout MAPS WM Technology Inc.
WM Technology Inc operates an online cannabis marketplace for consumers, together with a comprehensive set of e-commerce and compliance software solutions for cannabis businesses, which are sold to both storefront locations and delivery operators (retailers) and brands in the legalized cannabis markets in states and territories of the United States. Its comprehensive business-to-consumer and business-to-business suite of products affords cannabis retailers and brands of all sizes integrated tools to compliantly run their businesses and to reach, convert, and retain consumers.
About IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.